London · Delayed Price · Currency is GBP · Price in GBX Evoke Earnings Call Transcripts
Fiscal Year 2026
-
The AGM addressed the recommended acquisition by Bally's Intralot, reviewed improved profitability and operational progress in 2025, and outlined strategic responses to increased UK gaming duties. Sixteen resolutions were voted on, with results to be announced post-meeting.
Fiscal Year 2025
-
Revenue grew 2% to £1.8bn and adjusted EBITDA rose 14% to £356m, with strong Q4 momentum and improved margins. Strategic review is ongoing, retail optimization and AI investments are driving efficiency, and deleveraging remains a key focus.
-
Delivered fourth consecutive quarter of revenue growth and a 44% year-over-year increase in adjusted EBITDA, driven by strong international performance and operational improvements. Leverage reduced to 5x, with guidance for 5%-9% revenue growth and at least 20% EBITDA margin in 2025 reiterated.
-
The meeting highlighted a successful business transformation, renewed revenue growth, and a focus on customer acquisition and efficiency. A new Technology Committee was established to enhance governance. Management addressed shareholder questions and expects share price improvement as goals are achieved.
Fiscal Year 2024
-
2024 marked a successful turnaround with 3% revenue growth and 4% higher adjusted EBITDA, driven by transformation, cost efficiencies, and a focus on core markets. The outlook targets 5%-9% revenue growth and at least 20% EBITDA margin in 2025, with continued deleveraging and strategic investments.
-
H1 2024 saw a 2% revenue decline and lower-than-expected EBITDA, but corrective actions and strategic transformation are driving improved Q3 trading and set up for 5%-9% revenue growth in H2. Liquidity remains strong, and cost savings plus new product launches support profitability.
-
H1 2024 revenue was £862m, down 2% YoY but up 4% vs H2 2023, with underlying growth returning. EBITDA is expected £35m-£40m below plan, but cost savings, product innovation, and improved marketing are set to drive H2 revenue growth of 5%-9% and margin recovery. Confidence remains high for 2025 targets.